SUMA VARGHESE: Open Payments
NPI 1124516497 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 4 payments from 4 companies in 2025. Trend: 2023 $393 · 2024 $0 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $140 |
| ABBVIE INC. | 1 | $111 |
| Phathom Pharmaceuticals, Inc. | 1 | $110 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
Products named: INGREZZA, LINZESS, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
